Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Side portion of a circular saw blade
Method of manufacturing nitride semiconductor and nitride semiconductor element
Input system including position-detecting device
Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity
Digital rights management for media streams
Formwork release composition and use thereof
Apparatus for providing location information of hand-held device and method thereof
  Randomly Featured Patents
Telescopic optics with peripheral vision
Method and apparatus for a semiconductor device having a radiation part
Electrochemical cells and methods of electrolysis
Method of producing porous delivery devices
Automatic chest X-ray machine
Wind drag reducer for towed vehicles
Edge-triggered dual-rail dynamic flip-flop with an enhanced self-shut-off mechanism
Automatic transmission
Wireless communication unit and linearised transmitter circuit therefor